Over the next five years, global health is expected to see innovations in research, technology-enabled transformations, and measurable improvements to health outcomes by 2020. The volume of medicines used globally will reach 4.5 trillion doses and spending will reach $1.4 trillion, with China, India, Brazil and Indonesia accounting for nearly half of increased usage. Innovation will drive transformation of disease treatments with 225 new substances launched and over 470 drugs available to treat orphan diseases.

1. Global Health 2020
Over the next five years, we expect to see a surge of innovation emerging from
the research and development pipeline, as well as a range of technology-enabled
transformations that will expand the evidence-basis for interventions and bring
measurable improvements to health outcomes by 2020.
Learn more:
http://www.imshealth.com/en/thought-leadership/ims-institute
A look to 2020
The volume of medicines used globally will reach 4.5 trillion
doses and spending will reach $1.4 trillion.
More than 50% of the world’s population will live in
countries where average medicine consumption is more
than 1 dose per person per day, up from 33% of the world
in 2005.
• China, India, Brazil and Indonesia, with a combined
population of 3.23 billion in 2020, will account for nearly
half of the increased volume in medicine usage globally.
Global spending
on medicines in 2020
28% of global spending will be for specialty medicines,
especially in developed markets, with more than
$100 billion dedicated to oncology.
The key drivers of the spending growth over the
next five years:
• access expansion in pharmerging countries
• greater use of more expensive branded medicines
in developed markets
• increased availability of cheaper alternatives when
loss of exclusivity occurs
Innovation will drive
transformation of disease treatments
225 new active substances will be launched over the next five
years, bringing the total number since 1996 to more than 940.
Over 470 drugs will be available to treat orphan diseases for
the 7,000 rare diseases with no or limited treatments available.
Change is happening.